Working with Civil
Powerful chemotherapy drugs and estrogen-blocking hormone treatments are highly effective in treatin...
by Onawa Powell through Professor Rev. Dr. James Kenneth Powell II, opensourcebuddhism.org In this w...
Our own Henry Blodget and Nicholas Carlson discuss what could have turned a $550 million deal sour. ...
Turkey's prime minister walked off the stage at the World Economic Forum on Thursday after reproachi...
PubMed |
(0) (0 Votes)
|
Views: (1022) Date: (13-03-09) Pages: () |
Abstract: Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis. Yildir im K, Erdal A, Karatay S, Melikoglu MA, Ugur M, Senel K. Department of Physical Medicine and Rehabilitation, School of Medicine, Atat?rk University, Erzurum, Turkey. kadiryildirim88@hotm ail.com OBJECTIVES: The aims of this study were to investigate a possible relationship between the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and some acute phase reactant (APR) levels in patients with ankylosing spondylitis (AS). METHODS: Twenty outpatients who fulfilled the modified New York criteria for AS were included in the study. Laboratory activity was assessed by examining erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), haptoglobin (Hp), and beta2 microglobulin (beta2MG). Disease activity was assessed according to the BASDAI, which includes a 10-point visual analogue scale to measure pain, fatigue, morning stiffness, swelling, and areas of local tenderness. RESULTS: When APR values were analyzed for the BASDAI, a positive correlation between CRP and BASDAI was observed (r = 0.556, P < 0.05). There was no clear, statistically significant correlation between BASDAI and the other APRs (ESR, r = 0.328, P > 0.05; Hp, r = 0.035, P > 0.05; and beta2MG, r = -0.190, P > 0.05). CONCLUSIONS: Our data suggest that CRP is a better marker of disease activity than ESR, Hp, and beta2MG. PMID: 15108827 [PubMed - indexed for MEDLINE]